Structure-affinity relationship studies of non-competitive NMDA receptor antagonists derived from dexoxadrol and etoxadrol
- PMID: 16169732
- DOI: 10.1016/j.bmc.2005.07.030
Structure-affinity relationship studies of non-competitive NMDA receptor antagonists derived from dexoxadrol and etoxadrol
Abstract
The synthesis and NMDA receptor affinity of ring and side-chain homologues of etoxadrol and dexoxadrol are described. For the regioselective synthesis of etoxadrol homologues, the regioisomeric 4-azidobutanediols (+/-)-9 and (+/-)-14 were employed. A synthesis of the enantiomerically pure azidobutanediols (S)-, (R)-9 and (S)-, (R)-14 was developed and the homochiral building blocks were used for the synthesis of enantiomerically pure etoxadrol and dexoxadrol homologues. The affinity of the racemic and enantiomerically pure primary amines toward the phencyclidine binding site of the NMDA receptor was investigated in receptor binding studies with tritium labeled [3H]-(+)-MK-801 as radioligand. Benzaldehyde derivatives (+/-)-12a, (+/-)-13a, and (+/-)-16a bearing a proton at the acetalic position do not interact significantly with the NMDA receptor. An enantioselective NMDA receptor binding was observed for the trans-configured 2-(2-ethyl-2-phenyl-1,3-dioxolan-4-yl)ethanamine 13b, the (2-ethyl-2-phenyl-1,3-dioxan-4-yl)methanamine 16b, and the (2,2-diphenyl-1,3-dioxan-4-yl)methanamine 16c. The NMDA receptor affinity of these compounds resides almost exclusively in the (S)-configured enantiomers (2S,4S)-13b, (2S,4S)-16b, and (4S)-16c. The lowest Ki-value in this series was found for the (2S,4S)-configured 1,3-dioxolane (2S,4S)-13b (Ki = 69 nM), which is in the range of the Ki-value of the lead compounds etoxadrol and dexoxadrol, indicating that the 2-aminoethyl and the piperidin-2-yl substituents lead to similar NMDA receptor interactions.
Similar articles
-
Synthesis and SAR studies of chiral non-racemic dexoxadrol analogues as uncompetitive NMDA receptor antagonists.Bioorg Med Chem. 2010 Nov 15;18(22):7855-67. doi: 10.1016/j.bmc.2010.09.047. Epub 2010 Sep 25. Bioorg Med Chem. 2010. PMID: 20965735
-
Synthesis and NMDA-receptor affinity of ring and side chain homologous dexoxadrol derivatives.Arch Pharm (Weinheim). 2004 Feb;337(2):67-75. doi: 10.1002/ardp.200300821. Arch Pharm (Weinheim). 2004. PMID: 14981662
-
Relationships between the structure of dexoxadrol and etoxadrol analogues and their NMDA receptor affinity.Curr Top Med Chem. 2006;6(7):723-32. doi: 10.2174/156802606776894483. Curr Top Med Chem. 2006. PMID: 16719812 Review.
-
Synthesis of 4-(aminoalkyl) substituted 1,3-dioxanes as potent NMDA and σ receptor antagonists.Eur J Med Chem. 2011 Jun;46(6):2157-69. doi: 10.1016/j.ejmech.2011.02.070. Epub 2011 Mar 5. Eur J Med Chem. 2011. PMID: 21444132
-
Analogues of the dioxolanes dexoxadrol and etoxadrol as potential phencyclidine-like agents. Synthesis and structure-activity relationships.J Med Chem. 1992 Apr 17;35(8):1323-9. doi: 10.1021/jm00086a001. J Med Chem. 1992. PMID: 1349351
Cited by
-
Synthesis and biological activity of new 1,3-dioxolanes as potential antibacterial and antifungal compounds.Molecules. 2011 Aug 10;16(8):6806-15. doi: 10.3390/molecules16086806. Molecules. 2011. PMID: 21832971 Free PMC article.
-
Double Intramolecular Transacetalization of Polyhydroxy Acetals: Synthesis of Conformationally-Restricted 1,3-Dioxanes with Axially-Oriented Phenyl Moiety.Molecules. 2016 Nov 9;21(11):1503. doi: 10.3390/molecules21111503. Molecules. 2016. PMID: 27834880 Free PMC article.
-
Calcium Modulating Effect of Polycyclic Cages: A Suitable Therapeutic Approach Against Excitotoxic-induced Neurodegeneration.Mini Rev Med Chem. 2024;24(13):1277-1292. doi: 10.2174/0113895575273868231128104121. Mini Rev Med Chem. 2024. PMID: 38275027 Review.
-
Discovery of GluN2A subtype-selective N-methyl-d-aspartate (NMDA) receptor ligands.Acta Pharm Sin B. 2024 May;14(5):1987-2005. doi: 10.1016/j.apsb.2024.01.004. Epub 2024 Jan 10. Acta Pharm Sin B. 2024. PMID: 38799621 Free PMC article. Review.
-
Crystal structure of 5''-(4-chloro-benzyl-idene)-4'-(4-chloro-phen-yl)-1'-methyltri-spiro[acenapthylene-1,2'-pyrrolidine-3',1''-cyclo-hexane-3'',2'''-[1,3]dioxane]-2(1H),6''-dione.Acta Crystallogr E Crystallogr Commun. 2015 Oct 3;71(Pt 11):o814-5. doi: 10.1107/S2056989015018034. eCollection 2015 Nov 1. Acta Crystallogr E Crystallogr Commun. 2015. PMID: 26594541 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources